
Scientists just stumbled onto a hint that could totally change the game for how we diagnose CTE in living football players and anyone else who’s taken repeated hits to the head. This isn’t just some small medical blip, this is huge for player safety, and it’s something we’ve been needing for years. Right now, doctors are stuck evaluating symptoms like mood swings and memory loss to guess if someone has chronic traumatic encephalopathy, or CTE. But other nasty brain diseases cause the exact same issues, and the only way to actually confirm CTE has been a post-mortem brain examination. Until maybe, just maybe, now.
A Surprise Discovery From Alzheimer’s Research
Here’s the shocker: two small studies are showing us that a blood test developed to find abnormal tau protein in Alzheimer’s patients seems to also pick up that same protein buildup in folks with advanced CTE. Tau usually helps neurons do their job, but in Alzheimer’s, it tangles up inside those nerve cells, causing all sorts of problems. Researchers have been developing a blood test to track these tangles by looking for a specific tau fragment, eMTBR-tau243. The crazy part? Washington University in St. Louis researchers were using autopsy records to study this new test and found someone with sky-high levels of that biomarker who *didn’t* have Alzheimer’s, but CTE instead. Seriously, how wild is that?
They didn’t stop there, though. The WashU team dug into a bigger collection of autopsied brain and blood samples, testing blood from 11 people classified with CTE. What they found, according to assistant neurology professor Chihiro Sato, was that levels of eMTBR-tau243 were way higher in those with advanced CTE compared to healthy individuals. The kicker? It couldn’t reliably spot early-stage CTE. That news came out at a dementia meeting in Japan last week.
More Studies, More Complexity, But Real Hope
And it’s not just one study. Separately, researchers at Boston University and Arizona’s Banner Health were looking into the same question. They used stored blood from 21 former pro or school football players who had also donated their brains for research after they passed. Autopsies showed 16 of these players died with advanced CTE, two with earlier-stage CTE, and three didn’t have the disease at all. Their findings, presented at a scientific meeting in Boston, matched up: blood levels of that tau biomarker were significantly higher in the athletes with advanced CTE. What’s even more complex is that five of those CTE cases also had Alzheimer’s, which resulted in the absolute highest tau biomarker levels. Both studies, by the way, got published in the medical journal JAMA.
Look, Northwestern University neuropathologist Dr. Rudolph Castellani, who wasn’t involved in the research, is cautioning that this is “very preliminary” and needs way larger studies to prove a real connection. He’s right, of course. Abnormal tau shows up in a bunch of other brain diseases, and those can overlap in older adults. Plus, the tau buildup in CTE is different from the type in Alzheimer’s, according to Drs. Günter Höglinger and Carla Palleis of Germany’s Ludwig Maximilian University of Munich, who wrote an accompanying editorial. They also stressed that we need way more research. But here’s the thing: they also said these two studies together “represent an important step” in the quest to one day detect CTE in living patients. This isn’t just talk, this is a real clue, and for everyone who cares about player safety, that’s something to be genuinely excited about.
This article was created with AI assistance and published under Seattle On Tap’s editorial standards. See our Editorial Policy.
Originally reported by Bleacher Report.
Leave a Reply